Ignite Creation Date:
2025-12-24 @ 4:04 PM
Ignite Modification Date:
2026-02-21 @ 8:11 PM
Study NCT ID:
NCT02742766
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2016-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability and Preliminary Pharmacokinetics (PK) and Pharmacodynamics (PD) of Single and Repeat Oral Doses of GSK3008356 in Healthy and Obese Subjects
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-14
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-16
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-10
First Submit QC Date:
None
Study First Post Date:
2016-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-21
Results First Submit QC Date:
None
Results First Post Date:
2019-01-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-07-10
Last Update Post Date:
2019-07-24
Last Update Post Date Type:
ACTUAL